Welcome to our dedicated page for Hercules Capital SEC filings (Ticker: HTGC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Hercules Capital, Inc. filings document the regulatory reporting of a specialty finance company that provides senior secured venture growth loans to technology and life sciences businesses. Its Form 8-K filings cover earnings releases, operating and financial condition updates, cash distribution declarations, executive leadership changes and related exhibits.
Proxy materials describe annual meeting matters, board governance, executive compensation and equity-award disclosures. The company’s filings also identify its NYSE-listed common stock under HTGC and its 6.25% Notes due 2033 under HCXY, tying capital-structure disclosures to both equity and debt securities.
Hercules Capital director Paramjeet K. Randhawa reported an open-market purchase of 3,050 shares of common stock on March 4, 2026 at $14.78 per share. Following this trade, the director directly owns 19,560 shares, a figure that includes shares acquired through the company’s dividend reinvestment plan.
Hercules Capital director Paramjeet K. Randhawa reported an open-market purchase of 3,050 shares of common stock on March 4, 2026 at $14.78 per share. Following this trade, the director directly owns 19,560 shares, a figure that includes shares acquired through the company’s dividend reinvestment plan.
Hercules Capital, Inc. Chief Financial Officer Seth H. Meyer filed an amended insider trading report to correct an administrative error in the number of common shares previously reported as purchased. The amendment confirms his open-market purchase of 14,000 shares at an average price of $14.33 on February 27, 2026, and states that his total beneficial ownership of 448,553 shares was already correctly reported in the original Form 4.
Hercules Capital, Inc. Chief Financial Officer Seth H. Meyer filed an amended insider trading report to correct an administrative error in the number of common shares previously reported as purchased. The amendment confirms his open-market purchase of 14,000 shares at an average price of $14.33 on February 27, 2026, and states that his total beneficial ownership of 448,553 shares was already correctly reported in the original Form 4.
Hercules Capital, Inc. director Nikos Theodosopoulos reported an open-market purchase of common stock. He bought 2,600 shares at a price of $14.21 per share. Following this transaction, his directly held stake increased to 21,523 shares of Hercules Capital common stock.
Hercules Capital, Inc. director Nikos Theodosopoulos reported an open-market purchase of common stock. He bought 2,600 shares at a price of $14.21 per share. Following this transaction, his directly held stake increased to 21,523 shares of Hercules Capital common stock.
Hercules Capital, Inc. director Robert P. Badavas reported an indirect open-market purchase of 5,000 shares of common stock at $14.27 per share through the Robert P. Badavas Trust of 2007. Following this transaction, the trust holds 122,073 shares, and Badavas also reports 1,412 shares held directly.
Hercules Capital, Inc. director Robert P. Badavas reported an indirect open-market purchase of 5,000 shares of common stock at $14.27 per share through the Robert P. Badavas Trust of 2007. Following this transaction, the trust holds 122,073 shares, and Badavas also reports 1,412 shares held directly.
Hercules Capital, Inc. Chief Legal Officer & CCO Kiersten Zaza Botelho bought 1,300 shares of common stock in an open-market purchase at an average price of $14.21 per share. After this transaction, she directly owns 93,336 Hercules Capital common shares.
Hercules Capital, Inc. Chief Legal Officer & CCO Kiersten Zaza Botelho bought 1,300 shares of common stock in an open-market purchase at an average price of $14.21 per share. After this transaction, she directly owns 93,336 Hercules Capital common shares.
Hercules Capital director Thomas J. Fallon reported an open-market purchase of 20,000 shares of common stock at an average price of $14.20 per share. The filing notes the shares were bought at prices between $14.16 and $14.22 and are held indirectly by the Fallon Family Revocable Trust. Following this transaction, the trust holds 150,369 shares, and Fallon also reports 5,779 shares held directly.
Hercules Capital director Thomas J. Fallon reported an open-market purchase of 20,000 shares of common stock at an average price of $14.20 per share. The filing notes the shares were bought at prices between $14.16 and $14.22 and are held indirectly by the Fallon Family Revocable Trust. Following this transaction, the trust holds 150,369 shares, and Fallon also reports 5,779 shares held directly.
Hercules Capital, Inc. Chief Financial Officer Seth H. Meyer reported an open-market purchase of 7,000 shares of common stock. The shares were bought at an average price of $14.33 per share, with trade prices ranging between $14.30 and $14.35. Following this transaction, Meyer directly owns 448,553 shares of Hercules Capital common stock.
Hercules Capital, Inc. Chief Financial Officer Seth H. Meyer reported an open-market purchase of 7,000 shares of common stock. The shares were bought at an average price of $14.33 per share, with trade prices ranging between $14.30 and $14.35. Following this transaction, Meyer directly owns 448,553 shares of Hercules Capital common stock.
Hercules Capital, Inc. Chief Executive Officer Scott Bluestein reported an open-market purchase of 7,000 shares of common stock. The average purchase price was $14.35 per share, with trades executed between $14.30 and $14.36. Following this transaction, he directly owns 2,516,379 common shares.
Hercules Capital, Inc. Chief Executive Officer Scott Bluestein reported an open-market purchase of 7,000 shares of common stock. The average purchase price was $14.35 per share, with trades executed between $14.30 and $14.36. Following this transaction, he directly owns 2,516,379 common shares.
Hercules Capital director Wade Loo, through the Loo Revocable Trust, bought 3,300 shares of common stock in an open-market purchase at $14.98 per share. After this indirect purchase, the trust held 32,767 shares, and Loo also held 6,630 shares directly.
Hercules Capital director Wade Loo, through the Loo Revocable Trust, bought 3,300 shares of common stock in an open-market purchase at $14.98 per share. After this indirect purchase, the trust held 32,767 shares, and Loo also held 6,630 shares directly.
Hercules Capital, Inc. director Robert P. Badavas reported an open‑market purchase of 5,000 shares of common stock on behalf of the Robert P. Badavas Trust of 2007. The shares were bought at an average purchase price with trades executed between $15.01 and $15.02 per share.
After this transaction, the trust held a total of 117,073 Hercules Capital shares indirectly attributed to Badavas, while he also held 1,412 shares directly. This filing reflects a net increase in his overall reported ownership position in the company.
Hercules Capital, Inc. director Robert P. Badavas reported an open‑market purchase of 5,000 shares of common stock on behalf of the Robert P. Badavas Trust of 2007. The shares were bought at an average purchase price with trades executed between $15.01 and $15.02 per share.
After this transaction, the trust held a total of 117,073 Hercules Capital shares indirectly attributed to Badavas, while he also held 1,412 shares directly. This filing reflects a net increase in his overall reported ownership position in the company.